MyFinsight
Home
Blog
About
Contact
Download
Download image
Restricted cash security
deposit
$200K
In-process research and
development
$2,260K
Finance lease
right-of-use assets net
$5K
Operating lease
right-of-use assets net
$1,351K
Assets held for sale -
net
$70K
Leasehold improvements
and equipment net
$156K
Prepaid expenses and
other current assets
$168K
Restricted cash security
deposit
$50K
Cash and cash
equivalents
$5,435K
Total non-current
assets
$4,042K
Total current assets
$5,653K
Total assets
$9,695K
Total liabilities and
stockholders equity
$9,695K
Total stockholders
equity
$6,460K
Total liabilities
$3,235K
Accumulated deficit
-$208,875K
Additional paid-in capital
$215,334K
Total non-current
liabilities
$1,740K
Total current
liabilities
$1,495K
Common stock par value
0.0001 per share,...
$1K
Financing lease
liabilities net of current...
$11K
Operating lease
liabilities net of current...
$1,472K
Deferred tax liability
$257K
Financing lease
liabilities current
$5K
Operating lease
liabilities current
$846K
Accrued expenses
$564K
Accounts payable
$80K
Back
Back
Balance Sheet
source: myfinsight.com
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)